407 related articles for article (PubMed ID: 31210416)
1. KIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules.
Gwozdowicz S; Nestorowicz K; Graczyk-Pol E; Szlendak U; Rogatko-Koros M; Mika-Witkowska R; Pawliczak D; Zubala M; Malinowska A; Witkowska A; Nowak J
Int J Immunogenet; 2019 Aug; 46(4):217-231. PubMed ID: 31210416
[TBL] [Abstract][Full Text] [Related]
2. Coevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cells.
Older Aguilar AM; Guethlein LA; Adams EJ; Abi-Rached L; Moesta AK; Parham P
J Immunol; 2010 Oct; 185(7):4238-51. PubMed ID: 20805421
[TBL] [Abstract][Full Text] [Related]
3. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
[TBL] [Abstract][Full Text] [Related]
4. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
[TBL] [Abstract][Full Text] [Related]
5. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
Mansouri M; Villard J; Ramzi M; Alavianmehr A; Farjadian S
Hum Immunol; 2020 Jun; 81(6):285-292. PubMed ID: 32199702
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
[TBL] [Abstract][Full Text] [Related]
7. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
[TBL] [Abstract][Full Text] [Related]
8. Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.
Vineretsky KA; Karagas MR; Christensen BC; Kuriger-Laber JK; Perry AE; Storm CA; Nelson HH
Cancer Res; 2016 Jan; 76(2):370-6. PubMed ID: 26744525
[TBL] [Abstract][Full Text] [Related]
9. KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
Littera R; Piredda G; Argiolas D; Lai S; Congeddu E; Ragatzu P; Melis M; Carta E; Michittu MB; Valentini D; Cappai L; Porcella R; Alba F; Serra M; Loi V; Maddi R; Orrù S; La Nasa G; Caocci G; Cusano R; Arras M; Frongia M; Pani A; Carcassi C
PLoS One; 2017; 12(7):e0180831. PubMed ID: 28686681
[TBL] [Abstract][Full Text] [Related]
10. Receptor systems controlling natural killer cell function are genetically stratified in Europe.
Guinan KJ; Cunningham RT; Meenagh A; Dring MM; Middleton D; Gardiner CM
Genes Immun; 2010 Jan; 11(1):67-78. PubMed ID: 19693090
[TBL] [Abstract][Full Text] [Related]
11. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
12. HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma.
Beelen NA; Molenbroeck SJJ; Groeneveld L; Voorter CE; Bos GMJ; Wieten L
Immunogenetics; 2024 Jun; 76(3):155-164. PubMed ID: 38478091
[TBL] [Abstract][Full Text] [Related]
13. The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
Kandilarova SM; Paschen A; Mihaylova A; Ivanova M; Schadendorf D; Naumova E
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):73-81. PubMed ID: 28083606
[TBL] [Abstract][Full Text] [Related]
14. KIR3DL01 recognition of Bw4 ligands in the rhesus macaque: maintenance of Bw4 specificity since the divergence of apes and Old World monkeys.
Schafer JL; Colantonio AD; Neidermyer WJ; Dudley DM; Connole M; O'Connor DH; Evans DT
J Immunol; 2014 Feb; 192(4):1907-17. PubMed ID: 24453246
[TBL] [Abstract][Full Text] [Related]
15. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.
Yawata M; Yawata N; Draghi M; Little AM; Partheniou F; Parham P
J Exp Med; 2006 Mar; 203(3):633-45. PubMed ID: 16533882
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor.
Davies SM; Ruggieri L; DeFor T; Wagner JE; Weisdorf DJ; Miller JS; Velardi A; Blazar BR
Blood; 2002 Nov; 100(10):3825-7. PubMed ID: 12393440
[TBL] [Abstract][Full Text] [Related]
17. Resistance of KIR Ligand-Missing Leukocytes to NK Cells In Vivo in Patients with Acquired Aplastic Anemia.
Nguyen MAT; Hosokawa K; Yoroidaka T; Maruyama H; Espinoza JL; Elbadry MI; Mohiuddin M; Tanabe M; Katagiri T; Nakagawa N; Chonabayashi K; Yoshida Y; Arima N; Kashiwase K; Saji H; Ogawa S; Nakao S
Immunohorizons; 2020 Jul; 4(7):430-441. PubMed ID: 32680908
[TBL] [Abstract][Full Text] [Related]
18. [KIRs on human NK cells and in relation with HLA class I antigen--review].
Dou LP; Da WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):627-30. PubMed ID: 16800958
[TBL] [Abstract][Full Text] [Related]
19. Rhesus macaque KIR bind human MHC class I with broad specificity and recognize HLA-C more effectively than HLA-A and HLA-B.
Older Aguilar AM; Guethlein LA; Hermes M; Walter L; Parham P
Immunogenetics; 2011 Sep; 63(9):577-85. PubMed ID: 21614583
[TBL] [Abstract][Full Text] [Related]
20. Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia.
Cooley S; Weisdorf DJ; Guethlein LA; Klein JP; Wang T; Marsh SG; Spellman S; Haagenson MD; Saeturn K; Ladner M; Trachtenberg E; Parham P; Miller JS
J Immunol; 2014 May; 192(10):4592-600. PubMed ID: 24748496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
